U.S. markets closed

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392.SS)

Shanghai - Shanghai Delayed Price. Currency in CNY
Add to watchlist
290.48+10.23 (+3.65%)
At close: 3:00PM CST

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

No. 31 Kexueyuan Road
Changping District
Beijing 102206
86 10 5952 8888

Full Time Employees2,377

Key Executives

NameTitlePayExercisedYear Born
Zixin QiuDirector and Gen. Mang.N/AN/AN/A
Shayan LiDeputy Gen. Mang.N/AN/AN/A
Yimin LiDirector and Chief EngineerN/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.


Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. researches, develops, produces, distributes, and sells infectious disease diagnostic reagents and vaccines in China and internationally. The company provides COVID 19, HIV and HTLV, Hepatitis, EV-71, and Tuberculosis diagnostics test kits; Hepatitis C and Syphilis detection reagents; automated immunoassays; ELISA kits and rapid tests for infectious disease diagnostics; chemiluminescence and clinical chemistry reagents; immunodiagnostic reagents; and Hepatitis E and human papillomavirus vaccines. It serves blood banks, hospitals and clinics, reference laboratories, border inspection centers, blood-processing companies, and research institutes. The company was founded in 1991 and is headquartered in Beijing, China.

Corporate Governance

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.